InsiderTrades

Form 4 for NVAX NOVAVAX INC

Accepted 2021-10-19 00:00:00 ET · period of report 2021-10-15 · accession 0001209191-21-060946 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2021-10-19 2021-10-15 NVAX Glenn Gregory M Pres, R, D S - Sale+OE $170.00 -1,183 4,061 -23% -$201.1K
DM 2021-10-19 2021-10-15 NVAX Glenn Gregory M Pres, R, D M - OptEx $37.90 +1,183 5,244 +29% +$44.8K
DM 2021-10-19 2021-10-15 NVAX Glenn Gregory M Pres, R, D M - OptEx $0.00 -1,183 1,545 -43% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2021-10-15 S D 1,183 $170.00 4,061 D — —
2 Common Common Stock 2021-10-15 M A 521 $27.60 4,582 D — —
3 Common Common Stock 2021-10-15 M A 662 $46.00 5,244 D — —
4 Derivative Stock Option (Right to Buy) 2021-10-15 M D 662 $0.00 9,268 D $46.00 · — to 2028-12-13 662 Common Stock (F3) Twenty-five percent (25%) of the shares subject to this option grant under the Plan vested on the first anniversary of the December 13, 2018 grant date, and the remaining seventy-five percent (75%) of the shares vested or will vest in equal monthly installments over the following three (3) years subject to continued employment through such vesting date.
5 Derivative Stock Option (Right to Buy) 2021-10-15 M D 521 $0.00 1,545 D $27.60 · — to 2027-12-15 521 Common Stock (F2) Twenty-five percent (25%) of the shares subject to this option grant under the Novavax, Inc. Amended and Restated 2015 Stock Incentive Plan, as amended (the "Plan") vested on the first anniversary of the December 15, 2017 grant date, and the remaining seventy-five percent (75%) of the shares vested or will vest in equal monthly installments over the following three (3) years subject to continued employment through such vesting date.